SCHEMBL7912155

SCHEMBL7912155

Clc1cccc(Cl)c1Oc1nnc(-c2ccccc2)c2ccccc12

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 5/20 0.56
HTT P42858 4/20 0.56
MEN1 O00255 4/20 0.56
KMT2A Q03164 4/20 0.56
ALDH1A1 P00352 4/20 0.56
LMNA P02545 3/20 0.56
MAPT P10636 3/20 0.56
SMN1; SMN2 Q16637 2/20 0.50
RARG P13631 2/20 0.48
KDM4E B2RXH2 1/20 0.43
PDE5A O76074 1/20 0.43
CYP1A2 P05177 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
HPGD P15428 1/20 0.43
ALOX15 P16050 1/20 0.43
CYP2C19 P33261 1/20 0.43
PDE1A P54750 1/20 0.43
PDE1B Q01064 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7913419 0.84 NPSR1 (0.60) NPSR1HTTMEN1KMT2AALDH1A1
SCHEMBL27973382 0.81 NPSR1 (0.64) NPSR1HTTMEN1KMT2AALDH1A1
SCHEMBL27965124 0.78 KMT2A (0.79) NPSR1HTTMEN1KMT2AALDH1A1
SCHEMBL7913323 0.78 KMT2A (0.73) NPSR1HTTMEN1KMT2AALDH1A1
SCHEMBL7904890 0.78 NPSR1 (0.61) NPSR1HTTMEN1KMT2AALDH1A1
SCHEMBL7912157 0.77 LMNA (0.55) NPSR1HTTMEN1KMT2AALDH1A1
SCHEMBL7914884 0.73 ALDH1A1 (0.66) NPSR1HTTMEN1KMT2AALDH1A1
SCHEMBL4864061 0.73 HTT (0.60) NPSR1HTTMEN1KMT2AALDH1A1
SCHEMBL27956430 0.73 ALDH1A1 (0.69) NPSR1HTTMEN1KMT2AALDH1A1
SCHEMBL7918577 0.73 NPSR1 (0.61) NPSR1HTTMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6207666-B1 TREATING PRECANCEROUS LESIONS BY ADMINISTERING 4-PHENYLPHTHALAZINE DERIVATIVE CELL PATHWAYS, INC. 2001-03-27 US disclosed